The data from a report studying the effects of the prescription drug Xolair on individuals with moderate to severe asthma indicates a disproportionate increase in ischemic heart disease, arrhythmias, cardiomyopathy, cardiac failure, pulmonary hypertension, etc. according to the FDA. The study compared individuals taking Xolair compared and those not given the drug.
15 percent of individuals who used Xolair required hospitalization and there were 48 cases of people suffering severe allergic reactions, according to WebMD. Fortunately, no deaths have been reported with Xolair yet; though that doesn’t mean it won’t happen.
It’s interesting to note Xolair was approved by the FDA in 2003 but the study didn’t begin until 2004. I’ve always found it puzzling the FDA would approve the sale of a prescription drug without doing extensive tests on its potential adverse effects on people. It would make more sense for the FDA to flip the process – test first then release it to the public.
Here’s a video of the FDA warning over Xolair…
http://www.youtube.com/watch?v=Z3Yz73Hbrgo
Xolair is produced by Genentech. This company is no stranger to controversy. In 2008, a former Genentech employee filed a lawsuit against the company claiming they were discriminated against due to age and health problems. The plaintiff claims they were fired the day it was revealed they were diagnosed with a heart ailment, according to The Examiner.
As a personal injury lawyer with 20 years of experience representing clients who’ve been injured by prescription drugs, I believe a clear warning is necessary and a potential removal of Xolair from the prescription drug market in order to fully examine its effects on the human body. If you’ve suffered an allergic reaction using Xolair, I strongly recommend you consult an attorney.
About the Editors: Shapiro, Cooper Lewis & Appleton personal injury law firm is based in Virginia (VA), near the NE North Carolina (NC) border and handles car,truck,railroad, and medical negligence cases and more. Our lawyers proudly edit the Virginia Beach Injuryboard, Norfolk Injuryboard, and Northeast North Carolina Injuryboard as a pro bono public information service. Lawyers licensed in: VA, NC, SC, WV, DC, KY.
PA
Rick Shapiro has practiced personal injury law for over 30 years in Virginia, North Carolina, and throughout the Southeastern United States. He is a Board-Certified Civil Trial Advocate by the National Board of Trial Advocacy (ABA Accredited) and has litigated injury cases throughout the eastern United States, including wrongful death, trucking, faulty products, railroad, and medical negligence claims. During his three-decade career, Shapiro has won client appeals before the VA Supreme Court, VA Court of Appeals, NC Supreme Court, SC Supreme Court, WV Supreme Court, TN Supreme Court, and three times before the United States Court of Appeals for the Fourth Circuit, underscoring Shapiro’s trial achievements. In addition, he and his law firm have won settlements/verdicts in excess of $100 million. His success in and out of the courtroom is a big reason why he was named 2019 “Lawyer of the Year” in railroad law in U.S. News & World Report's Best Lawyers publication (Norfolk, VA area), and he has been named a “Best Lawyer” and “Super Lawyer” by those peer-reviewed organizations for multiple years. Rick was also named a “Leader in the Law, Class of 2022” by Virginia Lawyers Weekly (total of 33 statewide honorees consisting of lawyers and judges across Virginia). And in September 2023, Rick was selected as a recipient of the National Board of Trial Advocacy (NBTA) 2023 President’s Award. Although many nominations were submitted from across the country, Rick was just one of eight attorneys chosen by the prestigious National Board which certifies civil trial attorneys across the U.S. Rick was also recently named to Virginia Lawyers Weekly 2024 Virginia’s Go To Lawyers Medical Malpractice. The attorneys awarded this honor are nominated by their colleagues and chosen by a panel from the publication.
Comments for this article are closed.